Premier Inc.
04/06/2026 | Press release | Archived content
Court strikes HRSA 340B policy restricting initial hospital drug purchases through GPOs
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
The American Hospital Association reports that a federal court vacated a 2013 Health Resources and Services Administration (HRSA) policy restricting how certain 340B hospitals make initial drug purchases through group purchasing organizations. The ruling found the policy unlawful and ruled in favor of Premier Inc., which challenged the restriction. The decision could impact how hospitals participating in the 340B program manage outpatient drug purchasing strategies.
Read the full story from the American Hospital Association.
Premier Inc. published this content on April 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 08, 2026 at 16:41 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]